Depression and Anxiety Trial, Completed NCT03438656 Sponsor: University of Washington Condition: Depression and Anxiety
Back to Depression And Anxiety

Trial results

AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

According to the results reported on ClinicalTrials.gov, this trial (NCT03438656) involved 32 participants who were assigned to a single group called the "Behavioural Activation Arm." The trial was measuring changes in depression symptoms and feelings of loss of pleasure or interest (known as anhedonia) in the participants. Of the 32 people who started the trial, 30 completed it and 2 did not. The reported data shows two main outcomes. The first was depression symptoms, measured using a self-report questionnaire called the PHQ-9, which runs from 0 to 27 — where a higher number means more severe depression symptoms. The reported average score for participants was 9.63 out of 27. The second main outcome was a measure of anhedonia and engagement in daily activities, using a scale called the BADS, which runs from 0 to 150 — where a higher number represents less activity and engagement, and is considered a worse result. The reported average score on this measure was 61.80 out of 150. It is worth noting that several other things were also planned to be measured — including anxiety, behavioural problems, hopelessness, and suicidal thoughts — but no figures for those outcomes were included in the submitted results data. These are the results as reported to ClinicalTrials.gov. They are not medical advice — always discuss what they mean for you with your doctor.

These are the results as reported to ClinicalTrials.gov, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.

Depression and Anxiety Trial, Completed

NCT03438656
Completed Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • You have been diagnosed with depression (either minor or major depression) — this trial is for the Behavioral Activation treatment group

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • Your child has an IQ below 80
  • Either the young person or their parent does not speak English
  • The young person currently has a diagnosis of PTSD (post-traumatic stress disorder)
  • The young person has ever been diagnosed with a developmental condition (such as autism), a neurological condition (such as epilepsy), a psychotic disorder, bipolar disorder, or a substance use disorder
  • The young person is currently taking psychiatric medications (such as antidepressants) or other medications that affect mood (such as steroids), unless the medication is for ADHD
  • The young person's condition is serious enough to require hospital-level care, for example due to safety concerns related to suicidal thoughts or other mental or physical health problems
  • The young person is currently experiencing abuse or maltreatment of any kind
  • The young person has already completed a full course of another recognised, evidence-based treatment for depression

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Kids Helpline — 24/7, free and private for anyone aged 5 to 25: 1800 55 1800
  • headspace — mental health support for 12 to 25 year olds: headspace.org.au
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Completed
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2018
Est. completion
31 March 2023

Where this trial was run

🇺🇸 United States

These are the locations recorded on the registry, and they are a historical record: this trial is not enrolling, so they are not places you can join it.

Primary endpoints

Depression; Anhedonia/Activation

Other options

Expanded access pathways

This trial is not enrolling. Other access pathways exist in general: in Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients. Whether it applies to any treatment studied here is a question for your doctor — nothing on this page says it does.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov